University of New Mexico Cancer Center Support

新墨西哥大学癌症中心支持

• 批准号: 8138066
• 负责人: CHERYL LYNN WILLMAN
• 金额: $ 3.97万
• 依托单位: UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR
• 依托单位国家: 美国
• 财政年份: 2005
• 资助国家: 美国
• 起止时间: 2005-09-26 至 2015-08-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8138066
• 关键词: University; New; Mexico; Cancer; Center

Serving a vast geographic region of great beauty, with rich multicultural and multiethnic diversity, tremendous scientific opportunity, and challenging health and socioeconomic disparities, the University of New Mexico Cancer Center and its consortium institutions, Lovelace Respiratory Research Institute, Los Alamos National Laboratory, and Sandia National Laboratories, are uniquely poised to make significant advances in cancer research and to serve our communities and our nation. As the only NCI Cancer Center within a 500 mile radius, the special characteristics of the UNM Cancer Center include: the multiethnic and multicultural populations that it serves, primarily Hispanic/Latino, American Indian, and non-Hispanic White, with their strikingly different patterns of cancer incidence, mortality, and disparity; the integration of regional scientific strengths in engineering, biotechnology, nanotechnology, radioisotopes, drug discovery, imaging, and high performance computing into its Research Programs and Shared Resources; and the extensive statewide outreach networks it has built for the delivery of cancer care, for culturally appropriate community-based education and participatory research, and for the participation of community oncologists in UNM Cancer Center clinical trials. Since the previous NCI P30 CCSG review in 2005, the Center's annual peer-reviewed research funding has increased 40% to over $46.8 million dollars in total costs, while annual funding from NCI increased 30% to over $13.8 million dollars. Intra-programmatic and inter-programmatic collaborations among the 117 members of the Center have increased markedly and range from 20-48% in each of the 4 Research Programs: Cancer Population Sciences, Cancer Biology and Biotechnology, Hematologic Malignancies, and Women's Cancers. Cancer Center members lead one of 9 NIH-funded Roadmap Centers for High Throughput Target Screening and Molecular Discovery {U54MH084690), one of 10 NIH-funded National Centers for Systems Biology (P50GM085273), one of 4 NSF/NCI Centers for Integrative Nanoscience and Microsystems Training (DGE0504276), one of 20 LLS Specialized Centers of Leukemia Research (LLS SCOR 7388-06), and an Interdisciplinary HPV Prevention Center (NIH U19AI084081). To assure that all New Mexicans have access to outstanding cancer diagnosis and treatment, the UNM Cancer Center opened its new 206,432 sq. ft., $90 million, Cancer Treatment and Clinical Research Facility in August 2009 which serves as the hub of the UNM Statewide Cancer Care Network. In collaboration with Siemens, this new facility contains a radioisotope production laboratory and experimental radiopharmacy, which will accelerate the Center's research programs. From 7/1/08-7/1/09, while maintaining its mission to the underserved and uninsured, the UNM Cancer Center accrued 443 (17%) of the 2640 newly diagnosed patients treated at the Center to therapeutic clinical trials; 51% of these patients were Hispanic or American Indian. Community affiliates accrued another 101 patients to UNM therapeutic trials. In addition, the Center had 845 accruals to non-intervention protocols in this time period. The overall goals of the UNM Cancer Center are to: 1) conduct outstanding transdisciplinary research in our laboratories, clinics and multiethnic and multicultural communities that builds upon our unique scientific and regional strengths; 2) reduce the burden of cancer incidence and mortality by discovering the genetic, environmental, social, and behavioral factors that contribute to the distinct cancer patterns and cancer disparities in the peoples of the American Southwest; 3) translate our scientific discoveries to novel diagnostic, screening, prevention, and therapeutic tools and clinical trials; and 4) provide access to outstanding cancer treatment and clinical trials for all New Mexicans. The University of New Mexico Cancer Center serves a vast geographic region in the American Southwest with striking ethnic and cultural diversity and significant cancer health disparities. Its transdisciplinary research programs focus on integrating advanced scientific capabilities in nanotechnology, drug discovery, radioisotopes and imaging, engineering, and computing with biomedical science to make novel discoveries and translate these discoveries to new and more effective cancer diagnostics and therapeutics. It is focused on the delivery of outstanding care to the peoples of the region and overcoming their cancer health disparities through community programs and partnerships.

新墨西哥大学癌症中心及其联盟机构、洛夫莱斯呼吸研究所、洛斯阿拉莫斯国家实验室和桑迪亚国家实验室具有独特的优势，能够在癌症研究方面取得重大进展，并为我们的社区和国家服务。作为半径 500 英里内唯一的 NCI 癌症中心，新墨西哥大学癌症中心的特色包括： 它所服务的多种族和多文化人群，主要是西班牙裔/拉丁裔、美洲印第安人和非西班牙裔白人，其模式截然不同癌症发病率、死亡率和差异；将工程、生物技术、纳米技术、放射性同位素、药物发现、成像和高性能计算方面的区域科学优势整合到其研究计划和共享资源中；以及它为提供癌症护理、适合文化的社区教育和参与性研究以及社区肿瘤学家参与新墨西哥大学癌症中心临床试验而建立的广泛的全州外展网络。自 2005 年上一次 NCI P30 CCSG 审查以来，该中心的年度同行评审研究经费增加了 40%，总成本超过 4680 万美元，而 NCI 的年度资助增加了 30%，超过 1380 万美元。该中心 117 名成员之间的项目内和项目间合作显着增加，在 4 个研究项目中的每一个项目的合作比例从 20% 到 48% 不等：癌症人口科学、癌症生物学和生物技术、血液恶性肿瘤和女性癌症。癌症中心成员领导 NIH 资助的 9 个高通量目标筛选和分子发现路线图中心之一 (U54MH084690)、NIH 资助的 10 个国家系统生物学中心之一 (P50GM085273)、4 个 NSF/NCI 综合纳米科学中心之一和微系统培训 (DGE0504276)，20 个 LLS 专业之一白血病研究中心 (LLS SCOR 7388-06) 和跨学科 HPV 预防中心 (NIH U19AI084081)。为了确保所有新墨西哥州人都能获得出色的癌症诊断和治疗，新墨西哥州癌症中心于 2009 年 8 月启用了占地 206,432 平方英尺、耗资 9,000 万美元的新癌症治疗和临床研究设施，作为新墨西哥州全州癌症中心关爱网．与西门子合作，这个新设施包含一个放射性同位素生产实验室和实验放射性药剂室，这将加速该中心的研究计划。从 2008 年 7 月 1 日至 7 月 1 日，新墨西哥大学癌症中心在继续履行服务服务不足和未投保人群的使命的同时，在该中心治疗的 2640 名新诊断患者中，有 443 名 (17%) 参加了治疗性临床试验；其中 51% 的患者是西班牙裔或美洲印第安人。社区附属机构又招募了 101 名患者参加新墨西哥大学的治疗试验。此外，该中心在此期间对非干预方案进行了 845 项应计。新墨西哥大学癌症中心的总体目标是： 1）在我们的实验室、诊所以及多民族和多文化社区中开展出色的跨学科研究，这些研究建立在我们独特的科学和区域优势的基础上； 2) 通过发现导致美国西南部人民独特癌症模式和癌症差异的遗传、环境、社会和行为因素，减轻癌症发病率和死亡率的负担； 3) 将我们的科学发现转化为新的诊断、筛查、预防和治疗工具以及临床试验； 4) 为所有新墨西哥人提供出色的癌症治疗和临床试验。新墨西哥大学癌症中心为美国西南部广阔的地理区域提供服务，该区域具有显着的种族和文化多样性以及显着的癌症健康差异。其跨学科研究项目侧重于将纳米技术、药物发现、放射性同位素和成像、工程和计算方面的先进科学能力与生物医学相结合，以取得新的发现，并将这些发现转化为新的、更有效的癌症诊断和治疗方法。它的重点是为该地区人民提供卓越的护理，并通过社区计划和伙伴关系克服他们的癌症健康差距。